Enhanced Angiogenesis With Multimodal Cell-Based Gene Therapy

Annals of Thoracic Surgery

Volumn 83, Issue 3, 2007, Pages 1110-1119

  Yau, Terrence M ^a   Kim, Christopher ^a   Li, Guangming ^a   Zhang, Yaoguang ^a   Fazel, Shafie ^a   Spiegelstein, Dan ^a   Weisel, Richard D ^a   Li, Ren Ke ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; MICROSPHERE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL BASED GENE THERAPY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG POTENTIATION; ECHOCARDIOGRAPHY; FEMALE; GENE OVEREXPRESSION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HISTOLOGY; MALE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENE;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CORONARY CIRCULATION; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; GENE THERAPY; MALE; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; POSTOPERATIVE PERIOD; RATS; RATS, INBRED LEW; TRANSFECTION; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR FUNCTION, LEFT;

EID: 33847352477     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.10.050     Document Type: Article

References (22)

1. Yau T.M., Fung K., Weisel R.D., et al. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation 104 Suppl 1 (2001) 218-222
2. Yau T.M., Li G., Weisel R.D., et al. Vascular endothelial growth factor transgene expression in cell-transplanted hearts. J Thorac Cardiovasc Surg 127 (2004) 1180-1187
3. Yau T.M., Li G., Zhang Y., Weisel R.D., Mickle D.A., and Li R.K. Vascular endothelial growth factor receptor upregulation in response to cell-based angiogenic gene therapy. Ann Thorac Surg 79 (2005) 2056-2063
4. Liu T.B., Fedak P.W., Weisel R.D., et al. Enhanced IGF-1 expression improves smooth muscle cell engraftment after cell transplantation. Am J Physiol Heart Circ Physiol 287 (2004) H2840-H2849
5. Starvri G.T., Zachary I.C., Baskerville P.A., Martin J.F., and Erusalimsky J.D. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation 1 (1995) 11-14
6. Mandriota S., and Pepper M. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J Cell Sci 18 (1997) 2293-2302
7. Goto F., Goto K., Weindel K., and Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 5 (1993) 508-517
8. Couper L.L., Bryant S.R., Eldrup-Jorgensen J., Bredenberg C.E., and Lindner V. Vascular endothelial growth factor increases the mitogenic response to fibroblast growth factor-2 in vascular smooth muscle cells in vivo via expression of fms-like tyrosine kinase-1. Circ Res 6 (1997) 932-939
9. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
10. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
11. Yau T.M., Kim C., Li G., Zhang Y., Weisel R.D., and Li R.K. Maximizing ventricular function with multimodal cell-based gene therapy. Circulation 112 Suppl 1 (2005) 123-128
12. Lee R.J., Springer M.L., Blanco-Bose W.E., et al. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 22 (2000) 898-901
13. Arbiser J.L., Larsson H., Claesson-Welsh L., et al. Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo. Am J Pathol 156 (2000) 1469-1476
14. Tomita S., Li R.K., Weisel R.D., et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100 Suppl 19 (1999) II247-II256
15. Yau T.M., Tomita S., Weisel R.D., et al. Beneficial effect of autologous cell transplantation on infarcted heart function:comparison between bone marrow stromal cells and heart cells. Ann Thorac Surg 75 (2003) 169-176
16. Kim C., Li R.K., Li G., Zhang Y., Weisel R.D., and Yau T.M. Effects of cell-based angiogenic gene therapy at 6 months: persistent angiogenesis and absence of oncogenicity. Ann Thorac Surg 83 (2007) 640-646
17. Yau T.M., Kim C., Ng D., et al. Increasing transplanted cell survival with cell-based angiogenic gene therapy. Ann Thorac Surg 80 (2005) 1779-1786
18. Yamamoto M., Sakakibara Y., Nishimura K., Komeda M., and Tabata Y. Improved therapeutic efficacy in cardiomyocyte transplantation for myocardial infarction with release system of basic fibroblast growth factor. Artif Organs 27 (2003) 181-184
19. Sakakibara Y., Nishimura K., Tambara K., et al. Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg 124 (2002) 50-56
20. Laham R.J., Laham K., Pearlman J.D., et al. Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia. Ann Thorac Surg 70 (2000) 2113-2118
21. Sato K., Wu T., Laham R.J., et al. Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia. J Am Coll Cardiol 37 (2001) 616-623
22. Retuerto M.A., Schalch P., Patejunas G., et al. Angiogenic pretreatment improves the efficacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation. J Thorac Cardiovasc Surg 127 (2004) 1041-1049